GLP-1 Drugs and Sleep Apnea — A Breakthrough? - The Trial That Changed Everything

Julia Cartwright explores how tirzepatide (Zepbound) became the first FDA-approved medication for obstructive sleep apnea in adults with obesity. She examines the groundbreaking SURMOUNT-OSA trials, which showed dramatic reductions in breathing disruptions and achieved disease remission in up to 50% of participants, offering new hope beyond CPAP machines. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.